Kardigan Nets $460 Million in Nasdaq IPO as Clinical-Stage Cardiovascular Developer Lists
Kardigan, Inc. completed an initial public offering of 28,750,000 common shares at $16.00 apiece, producing gross proceeds of $460 million before underwriting fees and other expenses. The offering included the full exercise of an underwriters' option to purchase 3,750,000 additional shares. Shares trade on the Nasdaq Global Market under the ticker …